Factors Influencing Flu Vaccination in Primary Health Care

Flu, Human Clinical Trial

— FIVA  

Official title:

Factors Influencing Flu Vaccination in Primary Health Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04097197
• Other study ID #: FIVA_2019
• Status: Completed
• Phase: N/A
• Start date: October 14, 2019
• Est. completion date: March 31, 2020

Study information

• Verified date: May 2020
• Source: Agrupamento de Centros de Saúde de Dão Lafões
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to study the barriers to flu vaccination among at-risk people at the Primary Health Care level in order to increase the vaccination rates as recommended by the World Health Organization.

Description:

People from vulnerable groups (e.g., those diagnosed with Diabetes, Chronic Obstructive Pulmonary Disease, Asthma) are at increased risk of developing complications from infection with influenza virus, that could ultimately result in death.

Flu vaccination is recommended by many authorities, including the World Health Organization, as a means to decrease the risk of developing such life-threatening conditions. However, vaccination rates are well below the recommended threshold.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 197
• Est. completion date: March 31, 2020
• Est. primary completion date: March 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• People 65+ otherwise healthy;

• Patients of any age diagnosed with at least one of the following conditions: Diabetes, Asthma, COPD, Coronary Disease or Hearth failure;

• No history of flu vaccination in the previous year.

Exclusion Criteria:

• Patients who have been vaccinated against the flu but who have no record of it in the clinical records;

• Patients with contraindications to flu vaccination;

• Patients that cannot be reached either by phone or letter.

Related Conditions & MeSH terms

• Flu, Human
• Influenza, Human

Intervention

Behavioral:
• Brief educational intervention
same as before

Locations

Country	Name	City	State
Portugal	Dão Lafões Grouping of Primary Health Care Centres	Viseu	Dão Lafões

Sponsors (1)

Lead Sponsor	Collaborator
Agrupamento de Centros de Saúde de Dão Lafões

Country where clinical trial is conducted

Portugal, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Flu vaccination refusal rate	Percentage of patients refusing flu vaccination prior to intervention	up to 6 months
Secondary	Prevalence of barriers to flu vaccination	Percentage of participants mentioning a determined barrier to flu vaccination	up to 6 months
Secondary	Flu vaccination acceptance rate post-intervention	Percentage of patients who accept receiving the flu vaccine after receiving the intervention	up to 6 months
Secondary	Flu vaccination rate	Percentage of patients who have been vaccinated after the intervention	up to 6 months